IDEXX Laboratories, Inc.
IDXX
$556.93
$11.072.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.14B | 1.10B | 1.06B | 1.03B | 985.66M |
| Total Depreciation and Amortization | 154.08M | 148.80M | 145.18M | 140.17M | 137.67M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 227.43M | 222.63M | 204.67M | 173.71M | 73.13M |
| Change in Net Operating Assets | -149.66M | -256.58M | -227.51M | -253.23M | -290.65M |
| Cash from Operations | 1.37B | 1.21B | 1.18B | 1.09B | 905.81M |
| Capital Expenditure | -117.18M | -126.63M | -124.68M | -124.50M | -121.47M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 306.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.86M | -13.54M | -11.56M | -23.46M | -9.28M |
| Cash from Investing | -132.04M | -140.17M | -136.24M | -147.95M | -130.45M |
| Total Debt Issued | 190.00M | 460.50M | 398.00M | 205.00M | 329.00M |
| Total Debt Repaid | -325.00M | -428.39M | -428.39M | -103.39M | -178.39M |
| Issuance of Common Stock | 119.91M | 104.33M | 93.36M | 88.75M | 42.77M |
| Repurchase of Common Stock | -1.19B | -1.18B | -1.22B | -1.23B | -1.21B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.74M | -3.74M | -3.74M | -- | -- |
| Cash from Financing | -1.21B | -1.05B | -1.16B | -1.04B | -1.02B |
| Foreign Exchange rate Adjustments | -1.50M | 12.71M | 11.20M | 1.46M | 7.36M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.34M | 36.56M | -108.20M | -100.47M | -237.00M |